Year 2017 2018E 2019E 2020E: Patanjali Ayurved in Crs
Year 2017 2018E 2019E 2020E: Patanjali Ayurved in Crs
Year 2017 2018E 2019E 2020E: Patanjali Ayurved in Crs
0 1 2 3
Year 2017 2018E 2019E 2020E
Revenue 10000.00 15000.00 22500.00 33750.00
EBITDA 2000.00 3000.00 4500.00 6750.00
D&A <b> 80.00 120.00 180.00 270.00
EBIT 1920.00 2880.00 4320.00 6480.00
EBIT*(1-tax) <a> 1344.00 2016.00 3024.00 4536.00
Capex <c> 200.00 300.00 450.00 675.00
FCF to company (a+b-c) 1836.00 2754.00 4131.00
Terminal value (2023 onwards)
FCF + Terminal value 1836.00 2754.00 4131.00
Enterprise Value <d> ₹59,937.96
4 5 Assumptions
2021E 2022E Discount Rate 12%
50625.00 75937.50 Tax rate 30%
10125.00 15187.50 Revenue Growth 50%
405.00 607.50 EBITDA Margin 20%
9720.00 14580.00 D&A (% of Capex) 40%
6804.00 10206.00 Capex (% of Revenue) 2%
1012.50 1518.75
6196.50 9294.75
77456.25
6196.50 86751.00
Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.
Alternative Proxies: